Back to Search
Start Over
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells.
- Source :
-
International immunopharmacology [Int Immunopharmacol] 2012 Jul; Vol. 13 (3), pp. 308-15. Date of Electronic Publication: 2012 May 04. - Publication Year :
- 2012
-
Abstract
- Corilagin (beta-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-d-glucose), a gallotannin identified in several plants, including Phyllanthus urinaria, has been shown to exhibit versatile medicinal activities. As far as possible anti-inflammatory effects of corilagin, only few reports are available, and the potential use of corilagin as possible therapeutic molecule for cystic fibrosis has not been evaluated. In the present paper we report experiments aimed at determining the activity of corilagin on nuclear factor kappaB (NF-kappaB) binding to DNA target and on the expression of the major pro-inflammatory gene involved in cystic fibrosis, interleukin-8 (IL-8). Both IL-8 mRNA content and IL-8 protein secretion were analyzed in cystic fibrosis bronchial IB3-1 cells stimulated by tumor necrosis factor-alpha (TNF-alpha), one of the most potent pro-inflammatory agents. The data obtained demonstrate that corilagin binds to NF-kappaB, inhibits NF-kappaB/DNA interactions and affects IL-8 gene expression in TNF-alpha treated IB3-1 cells. In addition, corilagin inhibits TNF-alpha induced secretion of MCP-1 and RANTES, exhibiting low or no effect on the release of G-CSF, IL-6 and VEGF. Therefore, corilagin might be of interest for experimental anti-inflammatory therapy of cystic fibrosis.<br /> (Copyright © 2012. Published by Elsevier B.V.)
- Subjects :
- Anti-Inflammatory Agents, Non-Steroidal pharmacology
Base Sequence
Cell Line
Chemokine CCL2 metabolism
Chemokine CCL5 metabolism
Cystic Fibrosis genetics
Cystic Fibrosis immunology
Cystic Fibrosis metabolism
Cystic Fibrosis Transmembrane Conductance Regulator genetics
Down-Regulation drug effects
Humans
Hydrolyzable Tannins
Interleukin-8 metabolism
Mutation
NF-kappa B metabolism
RNA, Messenger genetics
RNA, Messenger metabolism
Tumor Necrosis Factor-alpha pharmacology
Cystic Fibrosis drug therapy
Glucosides pharmacology
Interleukin-8 genetics
NF-kappa B antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1878-1705
- Volume :
- 13
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- International immunopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 22561123
- Full Text :
- https://doi.org/10.1016/j.intimp.2012.04.010